Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-07-04
2006-07-04
Housel, James C. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S184100, C424S186100, C424S189100, C424S204100, C435S004000, C435S005000, C435S007100, C530S300000, C530S350000
Reexamination Certificate
active
07070790
ABSTRACT:
The nucleotide and deduced amino acid sequences of cDNAs encoding the envelope 1 genes and core genes of isolates of hepatitis C virus (HCV) are disclosed. The invention relates to the oligonucleotides, peptides and recombinant envelope 1 and core proteins derived from these sequences and their use in diagnostic methods and vaccines.
REFERENCES:
patent: 4870026 (1989-09-01), Wands et al.
patent: 5298410 (1994-03-01), Phillips et al.
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5427909 (1995-06-01), Okamoto et al.
patent: 5436126 (1995-07-01), Wang
patent: 5645983 (1997-07-01), Liao et al.
patent: 5856437 (1999-01-01), Miyamura et al.
patent: 6054264 (2000-04-01), Chien et al.
patent: 489968 (1992-06-01), None
patent: 0 586 065 (1994-03-01), None
patent: 221 251 1 (1992-01-01), None
patent: 05 068562 (1993-03-01), None
patent: WO 92 19743 (1992-11-01), None
patent: WO 92 21759 (1992-12-01), None
patent: WO 94 01778 (1994-01-01), None
patent: WO 94 25601 (1994-11-01), None
patent: WO 94 27153 (1994-11-01), None
patent: WO 95 01442 (1995-01-01), None
patent: WO 95/12677 (1995-05-01), None
Definition “vaccine”, The On-line Medical Dictionary, http://cancerweb.ncl.ac.uk/omd/.
Definition “vaccine”, Stedman's On-line Medical Dictionary, 27th Edition, http://www.stedmans.com.
Ferroni et al., Journal of Clinical Microbiology, vol. 31 No. 6, pp. 1586-1591 (Jun. 1993).
Shirai et al., Journal of Birology, vol. 68 No. 5, pp. 3334-3342 (May 1994).
Isaguliants et al., Vaccine, vol. 22, pp. 1656-1665 (2004).
Zein et al., Microbes and Infection, vol. 4, pp. 1237-1246 (2002).
Koff, Raymond, International Journal for Parasitology, vol. 33, pp. 517-533 (2003).
Seo-Hee Cho et al.: “Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region.” Biochemical and Biophysical Research Communications, vol. 196, No. 2, Oct. 29, 1993, pp. 780-788.
H.M. Müller et al.: “Genetic variability of German hepatitis C virus isolates” Journal of Medical Virology, vol. 40, 1993, pp. 291-306.
J.H. Han et al.: “Characterization of the terminal regions of hepititis C viral RNA: Identification of conserved sequences in the 5 -untranslated region and poly{A} tails at the 3' end.” Proc. Natl. Acad. Sci. USA, vol. 88, No. 5, Mar. 1, 1991, pp. 1711-1715.
H. Okamoto et al.: “Characterization of the genomic sequences of type V {or 3a} hepatitis C virus isolates and PCR primers for specific detection” Journal of General Virology, vol. 74, 1993, pp. 2385-2390.
A. Machida et al.: “Two distinct subtypes of Hepatitis C virus defined by antibodies directed to the putative core protein.” Hepatology, vol. 16, No. 4, Oct. 1992, pp. 886-891.
Simmonds P. et al., “Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions,”Journal of General Virology,5:1053-1061 (1994).
Kao, J.H. et al., “Detection of divergent hepatitis C virus envelope sequences,”Journal of Biomedical Science,3:158-162 (1994).
Roggendorf, M. et al., “Variability of the envelope regions of HCV in European isolates and its significance as a diagnostic tool,”Archives of Virology Supplementum,7:27-39 (1993).
Li, Ji-Su et al., “Identification of the third major genotype of hepatitis C virus in France”,Biochem. Biophys. Res. Commun.,1474-81 (1994).
Choo, O.L. et al. (1989)Science,244:359-362.
Weiner, A. J. et al. (1990)Lancet,335:1-3.
Kuo, G. et al. (1992)Science,244:362-364.
Okamoto, H. et al. (1992)J. Gen. Virol,73:673-679.
Bukh, J. et al. (1992)Proc. Natl. Acad. Sci. U.S.A.,89:187-191.
Bukh, J. et al. (1992)Proc. Natl. Acad. Sci. U.S.A.,89:4942-4946.
Cha, T. et al. (1992)Proc. Natl. Acad. Sci. U.S.A.,89:7144-148.
Chan S-W. et al. (1992)J. Gen. Virol.,73:1131-1141.
Lee, C-H. et al. (1992)J. Clin. Microbio,30:1602-1604.
Choo, et al. (1991)Proc. Natl. Acad. Sci. U.S.A.,88:2451-2455.
Okamoto, et al. (1992)Virology,188:331-341.
Inchauspe, et al. (1991)Proc. Natl. Acad. Sci. USA,88:10292-10296.
Takamizawa, A. et al. (1991)J. Virol.,65:1105-1113.
Kato, N. et al. (1990)Proc. Natl. Acad. Sci. U.S.A.,87:9524-9528.
Okamoto, H. et al. (1992)Virology,190:894-899.
Ogata, N. et al. (1991)Proc. Natl. Acad. Sci. U.S.A.,88:3392-3396.
Mori, S. et al. (1992)Biochem. Biophys. Res. Comm.,183:334-342.
Weiner, A.J. et al. (1991)Virology,180:842-848.
Hijikata, M. et al. (1991)Biochem. Biophys. Res. Comm.,175:220-228.
Okamoto, H. et al. (1990)Japan. J. Exp. Med.,60:167-177.
Takeuchi, K. et al. (1990)J. Gen. Virol.,71:3027-3033.
Chen P. J. et al. (1992)Virology,188:102-113.
Liu, K. et al. (1992)Gene,114:245-250.
Tanaka, T. et al. (1992)Virus Research,23:39-53.
Abe, K. et al. (1992)J. Gen. Virol.,73, 2725-2729.
Honda, M. et al. (1993)Arch. Virol.,128, 163-169.
Stuyver, L. et al. (1993)Biochem, Biophys. Res. Comm.,192:635-641.
Okamoto, H. et al. (1994)J. Gen. Virol.,75:629-635.
Bukh, J. et al. (1993)PNAS,90:8234-8238.
Li, J., et al. (1991)Gene,105:167-172.
Houghton, M. (1991)Hepatology,14:381-388.
Machida, A. et al. (1992)Hepatology,16:886-891.
Okamoto, H. et al. (1993)J. Gen. Virol.,74:2385-2390.
Simmonds, P., et al. (1993)J. Gen. Virol.,74:661-668.
Stuyver, L. et al. (1993)J. Gen. Virol.,74:1093-1102.
Widell, A. et al. (1994)J. Med. Virol.,44:272-279.
Qu D. et al. (1994)J. Gen. Virol.,75:1063-1070.
Simmonds, P. et al. (1994)J. Gen. Virol.,75:1053-1061.
Tokita, H., et al. (1994)J. Gen. Virol.,75:931-936.
Stuyver, L., et al. (1994)PNAS,91:10134-10138.
Vlazow, S., et al. (1994)J. Virol. Meth.,48:81-92.
Simmonds, P., et al. (1993)J. Clin. Microbiol.,31:1493-1503.
Hayashi, N., et al. (1993)J. Hepatol.,17 (suppl 3) S94-S107.
Wang, Y., et al. (1993)J. Med. Viro.,40:254-260.
Tanaka, T., et al. (1994)Hepatology,19:1347-1353.
Sakamoto, M., et al. (1994)J. Gen. Virol.,75:1761-1768.
Bukh Jens
Miller Roger H.
Purcell Robert H.
Housel James C.
Knobbe Martens Olson & Bear LLP
Lucas Zachariah
The United States of America as represented by the Department of
LandOfFree
Nucleotide and deduced amino acid sequences of the envelope... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and deduced amino acid sequences of the envelope..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and deduced amino acid sequences of the envelope... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3555435